430 related articles for article (PubMed ID: 2390105)
41. Characteristics of peroxisome proliferation: co-induction of peroxisomal fatty acid oxidation-related enzymes with microsomal laurate hydroxylase.
Kozuka H; Watanabe T; Horie S; Yamada J; Suga T; Ikeda T
Chem Pharm Bull (Tokyo); 1991 May; 39(5):1267-71. PubMed ID: 1914001
[TBL] [Abstract][Full Text] [Related]
42. The effect of hypolipidaemic agents on peroxisomal beta-oxidation and mixed-function oxidase activities in primary cultures of rat hepatocytes. Relationship between induction of palmitoyl-CoA oxidation and lauric acid hydroxylation.
Lake BG; Gray TJ; Pels Rijcken WR; Beamand JA; Gangolli SD
Xenobiotica; 1984 Mar; 14(3):269-76. PubMed ID: 6711016
[TBL] [Abstract][Full Text] [Related]
43. The effects of diquat and ciprofibrate on mRNA expression and catalytic activities of hepatic xenobiotic metabolizing and antioxidant enzymes in rat liver.
Gallagher EP; Buetler TM; Stapleton PL; Wang C; Stahl DL; Eaton DL
Toxicol Appl Pharmacol; 1995 Sep; 134(1):81-91. PubMed ID: 7676460
[TBL] [Abstract][Full Text] [Related]
44. Specificity in the action of hypolipidemic drugs: increase of peroxisomal beta-oxidation largely dissociated from hepatomegaly and peroxisome proliferation in the rat.
Lazarow PB; Shio H; Leroy-Houyet MA
J Lipid Res; 1982 Feb; 23(2):317-26. PubMed ID: 7077146
[TBL] [Abstract][Full Text] [Related]
45. Difference between guinea pig and rat in the liver peroxisomal response to equivalent plasmatic level of ciprofibrate.
Pacot C; Petit M; Rollin M; Behechti N; Moisant M; Deslex P; Althoff J; Lhuguenot JC; Latruffe N
Arch Biochem Biophys; 1996 Mar; 327(1):181-8. PubMed ID: 8615689
[TBL] [Abstract][Full Text] [Related]
46. Reduction of the concentrations of prostaglandins E2 and F2alpha, and thromboxane B2 in cultured rat hepatocytes treated with the peroxisome proliferator ciprofibrate.
Leung LK; Glauert HP
Toxicol Lett; 1996 Jun; 85(3):143-9. PubMed ID: 8644126
[TBL] [Abstract][Full Text] [Related]
47. Reduction of rat liver endoplasmic reticulum Ca(2+)-ATPase activity and mobilization of hepatic intracellular calcium by ciprofibrate, a peroxisome proliferator.
Bennett AM; Williams GM
Biochem Pharmacol; 1992 Feb; 43(3):595-605. PubMed ID: 1531754
[TBL] [Abstract][Full Text] [Related]
48. Rapid determination of rat hepatocyte mRNA induction potential using oligonucleotide probes for CYP1A1, 1A2, 3A and 4A1.
Surry DD; Meneses-Lorente G; Heavens R; Jack A; Evans DC
Xenobiotica; 2000 May; 30(5):441-56. PubMed ID: 10875679
[TBL] [Abstract][Full Text] [Related]
49. Characteristics of dehydroepiandrosterone as a peroxisome proliferator.
Yamada J; Sakuma M; Ikeda T; Fukuda K; Suga T
Biochim Biophys Acta; 1991 Apr; 1092(2):233-43. PubMed ID: 1673353
[TBL] [Abstract][Full Text] [Related]
50. Induction of microsomal NADPH-cytochrome P-450 reductase and cytochrome P-450IVA1 (P-450LA omega) by dehydroepiandrosterone in rats: a possible peroxisomal proliferator.
Wu HQ; Masset-Brown J; Tweedie DJ; Milewich L; Frenkel RA; Martin-Wixtrom C; Estabrook RW; Prough RA
Cancer Res; 1989 May; 49(9):2337-43. PubMed ID: 2523237
[TBL] [Abstract][Full Text] [Related]
51. Mechanisms of peroxisome proliferation by perfluorooctanoic acid and endogenous fatty acids.
Intrasuksri U; Rangwala SM; O'Brien M; Noonan DJ; Feller DR
Gen Pharmacol; 1998 Aug; 31(2):187-97. PubMed ID: 9688458
[TBL] [Abstract][Full Text] [Related]
52. An in vitro demonstration of peroxisome proliferation and increase in peroxisomal beta-oxidation system mRNAs in cultured rat hepatocytes treated with ciprofibrate.
Thangada S; Alvares K; Mangino M; Usman MI; Rao MS; Reddy JK
FEBS Lett; 1989 Jul; 250(2):205-10. PubMed ID: 2753129
[TBL] [Abstract][Full Text] [Related]
53. Toxicity and effects of 2,6-di-tert-butyl-4-methylphenyl N-methylcarbamate (terbutol) on hepatic cytochrome P450 in F344 rats.
Suzuki T; Nakagawa Y; Tayama K; Yaguchi K; Suga T
Arch Toxicol; 2001 Nov; 75(9):555-61. PubMed ID: 11760817
[TBL] [Abstract][Full Text] [Related]
54. Proliferation of peroxisomes and induction of peroxisomal beta-oxidation enzymes in rat hepatoma H4IIEC3 by ciprofibrate.
Osumi T; Yokota S; Hashimoto T
J Biochem; 1990 Oct; 108(4):614-21. PubMed ID: 2127277
[TBL] [Abstract][Full Text] [Related]
55. Comparison of constitutive and inducible levels of expression of peroxisomal beta-oxidation and catalase genes in liver and extrahepatic tissues of rat.
Nemali MR; Usuda N; Reddy MK; Oyasu K; Hashimoto T; Osumi T; Rao MS; Reddy JK
Cancer Res; 1988 Sep; 48(18):5316-24. PubMed ID: 2900680
[TBL] [Abstract][Full Text] [Related]
56. Effect of hypolipidemic compounds on lauric acid hydroxylation and phase II enzymes.
Thomas H; Schladt L; Knehr M; Post K; Oesch F; Boiteux-Antoine AF; Fournel-Gigleux S; Magdalou J; Siest G
Biochem Pharmacol; 1989 Jun; 38(12):1963-9. PubMed ID: 2500933
[TBL] [Abstract][Full Text] [Related]
57. Inhibitory effect of antioxidants ethoxyquin and 2(3)-tert-butyl-4-hydroxyanisole on hepatic tumorigenesis in rats fed ciprofibrate, a peroxisome proliferator.
Rao MS; Lalwani ND; Watanabe TK; Reddy JK
Cancer Res; 1984 Mar; 44(3):1072-6. PubMed ID: 6692393
[TBL] [Abstract][Full Text] [Related]
58. Age-related changes in the susceptibility to clofibric acid, a hypolipidemic agent, of male rat liver.
Yamoto T; Ohashi Y; Teranishi M; Takaoka M; Manabe S; Matsunuma N; Makita T
Toxicol Lett; 1995 Jul; 78(2):141-5. PubMed ID: 7618179
[TBL] [Abstract][Full Text] [Related]
59. Hepatic peroxisomal and microsomal enzyme induction by citral and linalool in rats.
Roffey SJ; Walker R; Gibson GG
Food Chem Toxicol; 1990 Jun; 28(6):403-8. PubMed ID: 2210513
[TBL] [Abstract][Full Text] [Related]
60. Irreversible inhibition of hepatic glutathione S-transferase by ciprofibrate, a peroxisome proliferator.
Awasthi YC; Singh SV; Goel SK; Reddy JK
Biochem Biophys Res Commun; 1984 Sep; 123(3):1012-8. PubMed ID: 6487318
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
